1. Home
  2. FBIO vs ICAD Comparison

FBIO vs ICAD Comparison

Compare FBIO & ICAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FBIO
  • ICAD
  • Stock Information
  • Founded
  • FBIO 2006
  • ICAD 1984
  • Country
  • FBIO United States
  • ICAD United States
  • Employees
  • FBIO N/A
  • ICAD N/A
  • Industry
  • FBIO Biotechnology: Pharmaceutical Preparations
  • ICAD Medical/Dental Instruments
  • Sector
  • FBIO Health Care
  • ICAD Health Care
  • Exchange
  • FBIO Nasdaq
  • ICAD Nasdaq
  • Market Cap
  • FBIO 39.4M
  • ICAD 40.8M
  • IPO Year
  • FBIO N/A
  • ICAD 1986
  • Fundamental
  • Price
  • FBIO $1.83
  • ICAD $1.84
  • Analyst Decision
  • FBIO Strong Buy
  • ICAD
  • Analyst Count
  • FBIO 3
  • ICAD 0
  • Target Price
  • FBIO $18.00
  • ICAD N/A
  • AVG Volume (30 Days)
  • FBIO 691.0K
  • ICAD 340.6K
  • Earning Date
  • FBIO 11-14-2024
  • ICAD 11-13-2024
  • Dividend Yield
  • FBIO N/A
  • ICAD N/A
  • EPS Growth
  • FBIO N/A
  • ICAD N/A
  • EPS
  • FBIO N/A
  • ICAD N/A
  • Revenue
  • FBIO $81,501,000.00
  • ICAD $18,940,000.00
  • Revenue This Year
  • FBIO N/A
  • ICAD $10.15
  • Revenue Next Year
  • FBIO $134.70
  • ICAD $3.75
  • P/E Ratio
  • FBIO N/A
  • ICAD N/A
  • Revenue Growth
  • FBIO 31.51
  • ICAD 10.03
  • 52 Week Low
  • FBIO $1.36
  • ICAD $1.18
  • 52 Week High
  • FBIO $4.43
  • ICAD $2.65
  • Technical
  • Relative Strength Index (RSI)
  • FBIO 49.60
  • ICAD 45.60
  • Support Level
  • FBIO $1.78
  • ICAD $1.70
  • Resistance Level
  • FBIO $2.27
  • ICAD $2.13
  • Average True Range (ATR)
  • FBIO 0.17
  • ICAD 0.16
  • MACD
  • FBIO -0.03
  • ICAD 0.00
  • Stochastic Oscillator
  • FBIO 21.43
  • ICAD 14.29

About FBIO Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.

About ICAD iCAD Inc.

icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment include advanced image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.

Share on Social Networks: